Dirofilariasis / Heartworm disease (Dirofilaria immitis)

Dirofilariasis, commonly known as heartworm disease, is a serious and potentially fatal parasitic infection caused by the nematode worm Dirofilaria immitis. While heartworm disease is most commonly associated with dogs, cats are also susceptible hosts, though the disease manifests quite differently in felines. In cats, heartworm infection causes a condition now recognized as Heartworm Associated Respiratory Disease (HARD), which can produce severe respiratory symptoms even when only a small number of worms are present. Unlike dogs, who may harbor dozens or even hundreds of adult worms, cats typically have infections of only one to three adult worms, yet these small numbers can cause significant and sometimes fatal disease.

The transmission of heartworm occurs exclusively through the bite of infected mosquitoes, making this a vector-borne disease rather than one that spreads directly between animals. When a mosquito feeds on an infected animal, it ingests microscopic larval heartworms called microfilariae. These larvae develop within the mosquito over approximately two weeks, then are transmitted to new hosts when the mosquito takes subsequent blood meals. Once inside a cat, the larvae migrate through body tissues over several months, eventually reaching the pulmonary arteries and, in some cases, the heart itself. The entire maturation process from infection to adult worms takes approximately eight months in cats.

The impact of heartworm disease on feline health is substantial and often unpredictable. Even during the larval migration phase before worms mature, cats can experience significant pulmonary inflammation and respiratory distress as their immune system responds aggressively to the parasites. Adult worms residing in the pulmonary arteries cause ongoing vascular inflammation, arterial damage, and impaired blood flow. Perhaps most concerning is that the death of even a single worm can trigger an acute and severe reaction causing sudden respiratory failure, collapse, or death. The small diameter of feline blood vessels means that worms and associated inflammatory debris can more readily cause complete obstruction compared to larger canine vessels.

Unlike heartworm disease in dogs, where established treatment protocols exist to kill adult worms, there is currently no approved or safe adulticide treatment for cats. The drugs used to eliminate adult heartworms in dogs are highly toxic to cats and carry unacceptable risks of fatal complications. Management of feline heartworm disease therefore focuses on supportive care, managing symptoms, reducing inflammation, and waiting for the adult worms to die naturally, which typically occurs within two to four years. Prevention is absolutely critical because treatment options are so limited. Monthly preventive medications are highly effective at preventing infection and should be used year-round in all cats, including indoor-only cats, as mosquitoes readily enter homes.

The sole cause of heartworm disease is infection with the parasitic nematode Dirofilaria immitis, transmitted exclusively through the bite of infected mosquitoes. Over 70 species of mosquitoes are capable of transmitting heartworm, making avoidance of mosquito bites extremely difficult for cats in endemic areas. The infection process begins when an infected mosquito deposits third-stage larvae (L3) onto the cat's skin during feeding; these larvae then enter through the bite wound. Within the cat's body, the larvae undergo two additional molts over approximately two to three months as they migrate through subcutaneous tissues toward the vascular system. The developing worms eventually reach the pulmonary arteries, where they mature into adults approximately six to seven months after initial infection.

Genetic and hereditary factors do not play a role in causing heartworm infection, as susceptibility depends entirely on exposure to infected mosquitoes rather than inherited characteristics. However, the feline immune response to heartworm infection does differ inherently from the canine response in ways that affect disease manifestation. Cats mount a more robust immune response against developing larvae, which means that many infections are cleared before reaching maturity. Studies suggest that only 25 to 40 percent of L3 larvae successfully develop to adulthood in cats, compared to much higher rates in dogs. This vigorous immune response, while protective against heavy worm burdens, also contributes to the inflammatory lung disease characteristic of feline heartworm infection.

Environmental and lifestyle factors significantly influence a cat's risk of heartworm exposure. Geographic location is paramount, as heartworm prevalence varies dramatically by region, with highest rates in warm, humid areas where mosquito populations thrive. The southeastern United States, Gulf Coast, Mississippi River valley, and Atlantic coast have historically had the highest heartworm prevalence, though climate changes have expanded the endemic range. Outdoor cats face greater mosquito exposure than indoor-only cats, but indoor cats remain at risk because mosquitoes readily enter buildings. Seasonal patterns exist in temperate climates, with transmission occurring primarily during warmer months when mosquitoes are active, though year-round transmission occurs in tropical and subtropical regions.

Risk factors for feline heartworm disease include any level of outdoor access, residence in endemic areas, lack of preventive medication, and proximity to bodies of water or other mosquito breeding habitats. Cats living with infected dogs face elevated risk because the dog serves as a reservoir host, increasing the likelihood that local mosquitoes carry the parasite. Interestingly, male cats appear to be diagnosed with heartworm disease more frequently than females, possibly due to behavioral differences affecting outdoor time and mosquito exposure. Cats of any age can become infected, though most diagnosed cases occur in cats between two and eight years of age. Feral and stray cats in endemic areas have high infection rates due to lack of preventive care.

The mechanism of disease development in cats involves both direct effects of the parasites and immunological responses to their presence. As larvae migrate through tissues, they trigger local inflammatory reactions. Upon reaching the pulmonary arteries, developing worms cause vascular inflammation (endarteritis) and remodeling that can persist even after worms die. The arrival of immature adult worms in the pulmonary vasculature triggers the inflammatory lung disease known as HARD, characterized by eosinophilic inflammation, bronchial constriction, and increased mucus production. When adult worms die, either naturally or prematurely, they decompose and release antigens that can trigger acute anaphylactic reactions, thromboembolism from worm fragments, and severe respiratory compromise. The unpredictable nature of these events makes feline heartworm disease particularly dangerous.

Early warning signs of heartworm disease in cats are often subtle, intermittent, and easily attributed to other conditions. In the initial months following infection, as larvae migrate through tissues and developing worms reach the pulmonary arteries, cats may exhibit mild respiratory symptoms including occasional coughing or slightly labored breathing. These early signs typically appear three to four months after infection and may resolve temporarily as the cat's immune system suppresses the developing infection. Some cats experience intermittent vomiting that seems unrelated to eating, decreased appetite, or mild lethargy during this phase. Many cat owners do not recognize these vague symptoms as indicative of a serious condition, particularly because cats characteristically hide signs of illness.

Coughing is one of the most common symptoms observed in cats with heartworm disease and may range from occasional soft coughs to frequent, severe coughing episodes that mimic feline asthma. The cough typically results from pulmonary inflammation and bronchial constriction caused by the immune response to parasites in the pulmonary arteries. Respiratory distress manifests as rapid breathing, open-mouth breathing, or visible effort when breathing. Some cats assume a crouched position with extended neck and head to ease breathing. Wheezing or harsh lung sounds may be audible. These respiratory symptoms can wax and wane, sometimes improving for weeks or months before returning, which can delay diagnosis as owners and veterinarians may attribute intermittent symptoms to asthma or bronchitis.

Behavioral changes in cats with heartworm disease reflect the chronic nature of the illness and associated discomfort. Affected cats often become less active and may sleep more than usual or avoid previously enjoyed activities such as playing or climbing. Appetite changes are common, with some cats eating less and losing weight gradually over time. Some cats experience episodes of vomiting that may or may not be associated with eating; this symptom is reported in approximately one-third of affected cats. Lethargy may become more pronounced as disease progresses. Cats may seek out quiet, secluded resting places and become less interactive with family members. Some owners notice their cats seem depressed or withdrawn compared to their normal personalities.

Physical signs of heartworm disease in cats can include weight loss and muscle wasting, particularly in chronic cases. The respiratory effort may be visibly increased, with exaggerated chest and abdominal movements during breathing. In severe cases, cats may have pale or bluish mucous membranes (gums, inner eyelids) indicating poor oxygenation. Fluid accumulation in the chest cavity (pleural effusion) or abdomen (ascites) may develop in cats with advanced disease or heart failure, causing abdominal distension or further respiratory compromise. Some cats develop a rounded, pot-bellied appearance. Rapid or irregular heart rhythms may be detected during veterinary examination. Syncope (fainting) episodes may occur in severely affected cats, particularly with exertion.

Symptom progression in feline heartworm disease does not follow a predictable linear pattern. Cats may experience acute episodes of severe symptoms interspersed with periods of apparent normalcy. The initial phase of Heartworm Associated Respiratory Disease typically occurs at three to four months post-infection, may partially resolve, then recur later as worms mature. Some cats remain asymptomatic for extended periods despite harboring adult worms, then suddenly develop severe symptoms. As worms age and eventually die, decomposition can trigger acute inflammatory crises. Chronic cases may show gradually worsening respiratory function, exercise intolerance, and declining body condition. The unpredictability of symptom progression makes monitoring challenging.

Emergency symptoms requiring immediate veterinary intervention include sudden onset of severe respiratory distress, collapse, inability to stand or walk, extreme weakness, or sudden death. Acute respiratory crises can occur when worms die or when worm fragments or blood clots obstruct pulmonary vessels. Cats experiencing such crises may breathe rapidly with open mouths, have blue-tinged gums, vocalize in distress, or become unresponsive. Sudden death can occur without preceding symptoms in some cats, making this disease particularly devastating. Any cat known to have heartworm disease who experiences acute worsening of symptoms requires emergency veterinary care. Even mild respiratory symptoms in cats from endemic areas warrant prompt veterinary evaluation given the serious nature of this condition.

The initial veterinary examination for suspected heartworm disease includes comprehensive physical assessment with particular attention to respiratory and cardiovascular systems. The veterinarian will listen carefully to heart and lung sounds, checking for abnormal heart rhythms, murmurs, and adventitious lung sounds such as crackles or wheezes. Respiratory rate and effort are evaluated, and mucous membrane color and capillary refill time are checked to assess oxygenation and circulation. Body condition is assessed for evidence of weight loss or muscle wasting. A thorough history is obtained regarding symptom onset, duration, and pattern; geographic location and travel history; outdoor access; and current use of heartworm prevention. The veterinarian will inquire about known exposure to other heartworm-positive animals.

Diagnostic testing for feline heartworm disease is more complex than in dogs because the tests available have significant limitations in cats. Antigen tests detect proteins produced by adult female heartworms and are highly specific when positive; however, because cats typically harbor few worms and infections may be single-sex (male only), antigen tests can be falsely negative in infected cats. Antibody tests detect the cat's immune response to heartworm exposure and are more sensitive for identifying infection, but positive results indicate exposure rather than current active infection, as antibodies persist after worm death. Using both antigen and antibody tests together provides the most complete picture. Thoracic radiographs (chest X-rays) are essential and may reveal characteristic changes including enlarged pulmonary arteries, bronchial patterns, or lung infiltrates. Echocardiography (cardiac ultrasound) can sometimes visualize adult worms in the pulmonary arteries or heart and assess cardiac function.

Differential diagnosis for cats presenting with respiratory symptoms consistent with heartworm disease includes several conditions that produce similar clinical pictures. Feline asthma is the most common differential and can be difficult to distinguish from Heartworm Associated Respiratory Disease; indeed, some cats may have both conditions. Bronchitis, pneumonia, and other respiratory infections can cause coughing and respiratory distress. Pulmonary neoplasia (lung cancer) may produce similar radiographic and clinical findings. Cardiomyopathy and other forms of heart disease can cause respiratory symptoms related to congestive heart failure. Lungworms, another parasitic infection, cause respiratory signs. Thorough diagnostic workup including heartworm testing, imaging, and sometimes bronchoscopy or bronchoalveolar lavage helps differentiate these conditions.

Confirmation of heartworm diagnosis in cats often requires integration of multiple test results and clinical findings rather than a single definitive test. A positive antigen test provides definitive confirmation of female worm infection, though negative results do not rule out disease. Positive antibody tests combined with compatible clinical signs and radiographic changes support a diagnosis even when antigen tests are negative. Visualization of worms on echocardiography provides definitive diagnosis when achievable. In some cases, diagnosis is presumptive based on the combination of exposure history, compatible clinical signs, characteristic radiographic changes, and exclusion of other causes. Necropsy examination, unfortunately, provides definitive diagnosis in cases of sudden death. Once diagnosis is established, the veterinarian will assess disease severity to guide management decisions and discuss the guarded prognosis with the cat's owner.

Emergency and immediate treatment for cats with acute heartworm crisis focuses on stabilization and supportive care. Cats in severe respiratory distress may require oxygen supplementation, which can be provided via oxygen cage, mask, or nasal cannula depending on the cat's tolerance. Corticosteroids are frequently administered to reduce the intense inflammatory response in the lungs and airways, with prednisolone or dexamethasone being commonly used. Bronchodilators may be given to ease airway constriction and improve breathing. Intravenous fluid therapy supports circulation while being carefully monitored to avoid fluid overload in cats with compromised cardiac function. Severely affected cats may require hospitalization in an intensive care setting with continuous monitoring until stabilized.

Medical management of feline heartworm disease differs fundamentally from canine treatment because there is no safe and effective adulticide therapy for cats. The arsenical compound melarsomine, used to kill adult heartworms in dogs, is contraindicated in cats due to severe and often fatal pulmonary reactions. Therefore, medical management focuses on reducing inflammation, managing symptoms, and supporting the cat while allowing adult worms to die naturally over two to four years. Corticosteroids remain the mainstay of medical therapy, used to control pulmonary inflammation during acute episodes and sometimes maintained at low doses for chronic management. Bronchodilators such as terbutaline or theophylline may be prescribed for cats with significant airway constriction. Monthly heartworm preventives should be administered to prevent new infections and eliminate any circulating microfilariae.

Surgical extraction of adult heartworms is possible and has been performed successfully in some cats, though it carries significant risks. Using specialized instruments and fluoroscopic guidance, worms can be physically removed from the pulmonary arteries and heart via jugular venotomy. This procedure is typically reserved for cats with heavy worm burdens, cats in which worms are visualized causing significant obstruction, or cats not responding to medical management. The procedure requires specialized expertise and equipment not available at all veterinary facilities. Complications can include vascular damage, hemorrhage, arrhythmias, and anaphylactic reactions. The decision to pursue surgical intervention involves careful consideration of risks versus benefits in each individual case.

Supportive care is central to managing cats with heartworm disease throughout the course of infection. Strict exercise restriction is recommended, particularly during acute episodes and for weeks following, as physical activity increases oxygen demand and can trigger crises. Nutritional support with high-quality, easily digestible food helps maintain body condition. Stress reduction is important, as stress can exacerbate respiratory symptoms and compromise immune function. Home environment modifications to minimize respiratory irritants such as cigarette smoke, strong fragrances, and dusty litter help reduce airway irritation. Regular monitoring at home for changes in breathing, activity level, or appetite allows for early recognition of worsening symptoms.

Complementary approaches may support cats with heartworm disease alongside conventional treatment. Omega-3 fatty acid supplementation has anti-inflammatory properties that may benefit cats with pulmonary inflammation. Antioxidant supplements may support overall health and immune function. Weight management prevents obesity-related respiratory compromise and reduces cardiac workload. Some practitioners employ acupuncture to support respiratory and cardiovascular function, though evidence specifically for feline heartworm disease is limited. Environmental modifications to improve air quality, such as air purifiers and avoidance of aerosol products, may reduce respiratory irritation. Any complementary therapies should be discussed with the attending veterinarian to ensure they do not interfere with prescribed treatments.

Treatment decisions for feline heartworm disease are highly individualized based on the cat's clinical status, worm burden if known, owner capabilities, and financial considerations. Cats with mild or no symptoms may be managed with preventive medication alone and monitoring, though owners must understand that acute crises can occur unpredictably. Cats with significant respiratory symptoms typically require corticosteroid therapy and supportive care. The costs of managing heartworm disease can be substantial, particularly for cats requiring hospitalization during acute crises or long-term medication. Unfortunately, because treatment options are limited and prognosis remains guarded regardless of intervention, some owners face difficult decisions about their cat's care. Veterinarians work with owners to develop management plans that optimize quality of life while acknowledging the serious nature of this disease.

Recovery timeline for cats with heartworm disease extends over years rather than weeks or months because there is no treatment to rapidly eliminate adult worms. Adult Dirofilaria immitis have a lifespan of approximately two to four years in cats, during which time the host must manage symptoms and monitor for complications. Cats experiencing acute respiratory crises may show improvement within days to weeks with appropriate supportive care and corticosteroid therapy, though they remain at risk for future episodes. During the multi-year period while worms are present, cats may experience fluctuating symptoms with periods of relative wellness interspersed with episodes of respiratory distress. The ultimate resolution of heartworm disease occurs when all adult worms have died, though residual vascular and pulmonary damage may persist.

Post-treatment care and ongoing management requirements are substantial for cats with heartworm disease. Activity restriction is often recommended indefinitely or at least during periods of symptom activity to reduce cardiac workload and oxygen demand. Monthly heartworm preventive medication must be continued to prevent new infections. Medications such as corticosteroids and bronchodilators may be needed long-term or during symptomatic periods. Home monitoring for changes in respiratory rate, breathing effort, appetite, and activity level helps detect early worsening. Follow-up veterinary appointments at regular intervals, typically every three to six months during active disease, allow for reassessment and treatment adjustments. Repeat diagnostic testing including radiographs and echocardiography may be performed periodically to monitor disease progression.

Prognosis for cats with heartworm disease is guarded and depends on multiple factors. Cats with small worm burdens, minimal cardiac involvement, and good response to supportive care may live for years with acceptable quality of life. However, the unpredictable nature of the disease means that sudden deterioration or death can occur even in cats that have been stable. Studies suggest that approximately one-third of heartworm-positive cats die or are euthanized due to their disease. Cats that survive the initial years until natural worm death may recover substantially, though permanent cardiovascular and pulmonary damage is possible. Quality of life during the disease course depends heavily on successful symptom management and the frequency and severity of acute episodes.

The long-term outlook for cats that survive heartworm disease and outlive their worm burden is cautiously optimistic. Once all worms have died and the acute risks have passed, many cats show significant clinical improvement and can return to relatively normal lives. However, vascular and pulmonary remodeling that occurred during active infection may cause persistent changes visible on radiographs and potentially contributing to ongoing mild respiratory symptoms. Cats that have recovered from heartworm disease should continue monthly preventive medication for life to prevent reinfection. Regular veterinary monitoring remains important to assess for long-term complications. Owners of cats that survive heartworm disease often become strong advocates for prevention, understanding firsthand the serious nature of this condition and the importance of protecting other cats from similar experiences.

Primary prevention of heartworm disease in cats relies on monthly administration of preventive medications that kill developing larvae before they can mature into adult worms. Several FDA-approved heartworm preventives are available for cats, including oral medications (milbemycin oxime, ivermectin), topical products (selamectin, moxidectin), and injectable formulations. These products work by eliminating larvae acquired during the preceding month, providing retroactive protection when administered consistently. Preventive medication is recommended for all cats, including indoor-only cats, because mosquitoes readily enter homes and even brief exposure can result in infection. Year-round administration is recommended regardless of geographic location, as transmission patterns can vary and skipping months creates vulnerability.

Environmental prevention focuses on reducing mosquito exposure, though this can only supplement rather than replace pharmaceutical prevention. Keeping cats indoors during peak mosquito activity times, typically dawn and dusk, reduces exposure somewhat. Eliminating standing water around the home removes mosquito breeding sites. Using screens on windows and doors helps prevent mosquito entry. Mosquito repellent products labeled specifically for cats may provide some additional protection, though many products safe for dogs or humans are toxic to cats. Environmental mosquito control in the yard through larvicides or professional pest management reduces local mosquito populations. Despite these measures, complete elimination of mosquito exposure is impossible, reinforcing the need for preventive medication.

Dietary approaches to heartworm prevention are not effective as standalone measures, though good nutrition supports overall immune function and health. There are no foods, supplements, or natural remedies proven to prevent heartworm infection in cats. Products marketed as natural heartworm preventives have not demonstrated efficacy in preventing infection and should not be substituted for proven pharmaceutical preventives. Maintaining cats at a healthy weight through appropriate diet supports cardiovascular health, which is beneficial for cats at risk of or affected by heartworm disease. A balanced, high-quality diet supports immune function, which may influence the cat's response to any parasite exposure, but cannot prevent establishment of infection.

Health maintenance through regular veterinary care is essential for optimal heartworm prevention and early detection. Annual or more frequent wellness examinations provide opportunities to discuss heartworm prevention compliance and refill preventive medications. Veterinarians in endemic areas may recommend annual heartworm testing even for cats on preventive medications to ensure protection is adequate and to detect any breakthrough infections. Discussion of any lapses in preventive medication administration allows veterinarians to recommend appropriate testing and catch-up protocols. Keeping records of preventive administration helps ensure consistency. For cats traveling to or relocating from different geographic areas, veterinary consultation ensures appropriate preventive protocols for the level of heartworm risk.

Early intervention and vigilance are particularly important given the serious consequences of feline heartworm disease. Starting preventive medication in kittens, typically at eight weeks of age, provides protection from the earliest possible time. Any cat not previously on preventive medication should be tested before starting prevention to establish baseline status, though starting prevention should not be delayed pending test results in endemic areas. Cats with unknown history, such as newly adopted shelter or stray cats, should receive immediate prevention and appropriate testing. Any lapse in prevention, even a single missed dose in endemic areas, warrants discussion with the veterinarian and potentially follow-up testing. Because treatment options are so limited and outcomes can be devastating, commitment to consistent, year-round prevention is the most important action cat owners can take to protect their pets from heartworm disease.

Daily management of a cat with heartworm disease requires consistent attention to the cat's condition and adherence to veterinary recommendations. Administering prescribed medications at consistent times helps maintain therapeutic levels and establish routine. Observing the cat's breathing at rest each day provides important monitoring information; counting respiratory rate by watching chest movements for 30 seconds and doubling the number establishes baseline data, with rates consistently above 40 breaths per minute at rest warranting veterinary consultation. Monitoring appetite and food intake helps detect early changes that may indicate worsening condition. Keeping activity levels low and discouraging strenuous play or exercise reduces cardiac workload and risk of respiratory crises. Maintaining a calm, stress-free environment supports overall health and immune function.

Home environment modifications help support cats with heartworm disease and reduce factors that could worsen respiratory symptoms. Eliminating cigarette smoke and avoiding strong fragrances, aerosol sprays, scented candles, and air fresheners reduces airway irritation. Using low-dust or dust-free cat litter prevents inhalation of irritating particles. Ensuring good air quality through ventilation or air purification benefits respiratory function. Keeping the home at comfortable temperature extremes and avoiding extreme temperature changes reduces respiratory stress. Providing easily accessible food, water, and litter boxes on a single floor minimizes necessary exertion. Creating quiet, comfortable resting areas allows cats to rest undisturbed.

Maintaining quality of life for cats with heartworm disease remains achievable with appropriate management despite the serious nature of the condition. Gentle interaction, petting, and grooming provide comfort and maintain the human-animal bond without requiring physical exertion. Mental stimulation through window perches, bird feeders outside windows, and calm interactive play with toys keeps cats engaged without overexertion. Maintaining familiar routines and environments reduces stress. Some cats with well-controlled disease enjoy nearly normal lives during periods between symptomatic episodes. Recognizing that quality of life matters as much as quantity helps guide management decisions and allows owners to focus on making comfortable, happy experiences available to their cats.

Ongoing monitoring and veterinary care are essential components of living with a heartworm-positive cat. Regularly scheduled veterinary appointments allow for assessment of disease progression and treatment response. Home monitoring between appointments includes tracking respiratory rate, noting any coughing or breathing difficulty, observing appetite and activity levels, and watching for any sudden changes. Keeping a simple journal of daily observations helps identify trends and provides valuable information for veterinary visits. Understanding warning signs that require immediate veterinary attention empowers owners to respond appropriately to emergencies. Clear communication with the veterinary team about changes in the cat's condition ensures timely intervention when needed.

Caregiver support is important when managing the challenges of a cat with heartworm disease. The emotional toll of caring for a pet with a serious, unpredictable illness can be significant. Connecting with online communities of owners managing similar conditions provides emotional support and practical tips. Discussing concerns, fears, and difficult decisions with veterinary staff helps process the emotional aspects of caregiving. Understanding that some factors are beyond control despite best efforts helps manage guilt and anxiety. Planning for financial aspects of ongoing care prevents unexpected stress. For some families, counseling or support groups can help cope with anticipatory grief or the challenges of difficult decisions. Recognizing the importance of self-care for caregivers ultimately benefits both the owner and the cat.

Heartworm disease does not show specific breed predisposition in cats, as susceptibility depends entirely on mosquito exposure and transmission of the Dirofilaria immitis parasite rather than genetic factors. All cats, regardless of breed, are susceptible to infection when bitten by an infected mosquito. Unlike some hereditary or congenital conditions that affect certain breeds disproportionately, heartworm is an acquired infectious disease affecting the feline population broadly. Studies of heartworm prevalence have not identified any breeds with significantly higher or lower infection rates when environmental factors are controlled. The primary determinants of risk are geographic location, outdoor access, and use of preventive medications rather than breed characteristics.

While no breeds face inherently higher risk, certain categories of cats experience greater heartworm exposure based on lifestyle factors. Outdoor and indoor-outdoor cats have higher infection rates than strictly indoor cats due to increased mosquito exposure. Feral and stray cat populations in endemic areas show high infection rates because they lack preventive care and have constant outdoor exposure. Cats in shelters may have elevated risk if they were previously outdoor cats or lived in endemic areas without prevention. Working cats such as barn cats face continual outdoor exposure. Cats living in households with heartworm-positive dogs may face elevated transmission risk, as the infected dog serves as a reservoir increasing local mosquito infection rates. Male cats appear to be diagnosed more frequently than females, possibly related to behavioral differences affecting outdoor time.

Screening recommendations for heartworm in cats are based on geographic risk and lifestyle factors rather than breed. The American Heartworm Society recommends annual testing for cats in endemic areas, even those receiving preventive medications, to ensure protection is adequate. Testing is recommended before starting preventive medication in adult cats to establish baseline status. Cats with respiratory symptoms consistent with Heartworm Associated Respiratory Disease should be tested regardless of perceived risk. Newly adopted cats with unknown history should be tested, particularly if originating from endemic regions. Cats not currently on prevention who will be starting preventives should be tested. Retesting may be recommended after lapses in prevention. Breeders and catteries in endemic areas should ensure all cats receive appropriate prevention and testing as part of health management protocols.

Heartworm disease commonly co-occurs with or is complicated by respiratory conditions that may share similar clinical presentations. Feline asthma and Heartworm Associated Respiratory Disease (HARD) can occur simultaneously and may be difficult to differentiate clinically, as both cause coughing, wheezing, and respiratory distress. Some researchers believe that heartworm infection may actually trigger or exacerbate asthmatic disease in some cats. Chronic bronchitis and bronchiectasis can develop secondary to the ongoing pulmonary inflammation caused by heartworm infection. Secondary bacterial pneumonia may occur in cats with compromised respiratory defenses. Cats with underlying heart disease such as hypertrophic cardiomyopathy may experience accelerated cardiac compromise when heartworm infection adds additional cardiovascular stress. Managing cats with multiple concurrent conditions requires careful coordination of treatments.

Several conditions produce symptoms similar to heartworm disease and must be considered in the differential diagnosis. Feline asthma is the most common condition confused with HARD, causing coughing, wheezing, and episodic respiratory distress. Bronchitis and pneumonia cause respiratory symptoms that can mimic heartworm disease. Lungworm infections, particularly with Aelurostrongylus abstrusus, cause pulmonary disease with coughing and respiratory distress. Pulmonary neoplasia, including primary lung tumors and metastatic cancer, can cause similar radiographic and clinical findings. Cardiac disease from causes other than heartworm, including hypertrophic cardiomyopathy and congestive heart failure, produces respiratory symptoms. Pleural effusion from various causes can cause respiratory distress. Thorough diagnostic workup is essential to accurately identify the underlying condition and guide appropriate treatment.

Complications of heartworm disease can affect multiple organ systems beyond the heart and lungs. Thromboembolism, the obstruction of blood vessels by clots or worm fragments, can occur in pulmonary vessels or systemically, potentially causing acute collapse, respiratory failure, or sudden death. Aberrant larval migration can rarely result in worms lodging in unusual locations such as the brain, eyes, or peripheral arteries, causing neurological signs, blindness, or limb ischemia. Immune-mediated complications including glomerulonephritis from immune complex deposition can affect kidney function. Right-sided heart failure may develop in cats with significant cardiac involvement. Caval syndrome, a life-threatening condition where worms obstruct blood flow through the vena cava, can occur in cats with heavy burdens. Recognizing and managing these complications promptly is essential for optimizing outcomes, though the occurrence of serious complications often indicates poor overall prognosis.